The Long Run with Luke Timmerman

A podcast by Timmerman Report

173 Episodes

  1. Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

    Published: 3/16/2025

  2. Ep174: Najat Khan on the TechBio Movement

    Published: 3/3/2025

  3. Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

    Published: 2/11/2025

  4. Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

    Published: 1/27/2025

  5. Ep171: Ram Aiyar on RNA Editing Medicines

    Published: 1/13/2025

  6. Ep170: David Schenkein on Investing in the Future of Biotech

    Published: 1/2/2025

  7. Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

    Published: 12/11/2024

  8. Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

    Published: 11/25/2024

  9. Ep167: Leslie Williams on transfer RNA therapies

    Published: 11/6/2024

  10. Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

    Published: 10/15/2024

  11. Ep165: Zach Hornby on Tackling Cancer Drug Resistance

    Published: 9/26/2024

  12. Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

    Published: 9/5/2024

  13. Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

    Published: 8/14/2024

  14. Ep162: Sean McClain on AI for Biologic Drug Discovery

    Published: 7/16/2024

  15. Ep161: Jeff Stein on a Long-Lasting Flu Drug

    Published: 7/1/2024

  16. Ep160: Abe Ceesay on Precision Neuroscience

    Published: 6/17/2024

  17. Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Published: 6/3/2024

  18. Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    Published: 5/20/2024

  19. Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

    Published: 5/1/2024

  20. Ep156: David Liu on New Tools and Techniques for Biology

    Published: 4/16/2024

1 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.